Indications of Naprosyn Plus 375 mg 20 mg

It is indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and ankylosing spondylitis and to decrease the risk of developing gastric ulcers in patients at risk of developing NSAID-associated gastric ulcers.

Theropeutic Class

Drugs for Osteoarthritis, Drugs used for Rheumatoid Arthritis, Non-steroidal Anti-inflammatory Drugs (NSAIDs)

Pharmacology

It is a preparation of Naproxen and Esomeprazole. Naproxen is a NSAID with analgesic and antipyretic activities. It inhibits prostaglandin synthesis. Esomeprazole is a proton pump inhibitor that suppresses gastric acid secretion by specific inhibition of the H /K ATPase in the gastric parietal cell. By acting specifically on the proton pump. Esomeprazole blocks the final step in acid production, thus reducing gastric acidity.

Dosage and Administration of Naprosyn Plus 375 mg 20 mg

The recommended dose is one tablet twice daily. Do not split, chew, crush or dissolve the tablet. This tablet is to be taken at least 30 minutes before meals.

Interaction of Naprosyn Plus 375 mg 20 mg

ACE Inhibitors, diuretics and beta-blockers: may reduce the antihypertensive effect.Cyclosporin: increases the risk of nephrotoxicity.Lithium: increases plasma level of lithium.Methotrexate: may increase the serum levels of methotrexate.Warfarin: may increase the risk of bleeding complications.Digoxin: may increase the digoxin toxicity.Clopidogrel: may decrease the exposure to the active metabolite of clopidogrel.

Contraindications

It is contraindicated in patients with known hypersensitivity to any components of this products. It is also contraindicated in patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs and for the treatment of per-operative pain in the setting of coronary artery bypass graft (CABG) surgery.

Side Effects of Naprosyn Plus 375 mg 20 mg

The most common side effects are gastritis, erosive gastritis, dyspepsia, diarrhea, gastric ulcer, upper abdominal pain and nausea etc.

Pregnancy and Lactation

The use of this tablet should be avoided in pregnancy and lactation unless the potential benefits to the other outweigh the possible risks to the fetus.

Precautions and Warnings

Caution should be exercised in following conditions: Fatal cardiovascular thrombotic events like myocardial infarction, stroke, hypertension, congestive heart failure and edema. Serious GI adverse events. Hypomagnesaemia. Renal or hepatic insufficiency.

Storage Conditions

Keep in a dry place away from light and heat. Keep out of the reach of children.

Disclaimer

The information provided is accurate to our best practices, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy. The absence of specific information about a drug should not be seen as an endorsement. We are not responsible for any consequences resulting from this information, so consult a healthcare professional for any concerns or questions.